Simple Summary The epithelial to mesenchymal transition (EMT) is a well-documented
process in the study of cancer metastases. The cytoskeleton is an intricate network involved …

In recent years, there has been a surge of interest in using machine learning algorithms
(MLAs) in oncology, particularly for biomedical applications such as drug discovery, drug …

Simple Summary Microtubule-targeting agents are a class of chemotherapeutics used to
treat triple-negative breast cancer (TNBC). These include drugs such as eribulin that …

Triple-negative breast cancer (TNBC) is one of the most heterogeneous and aggressive
breast cancer subtypes with a high risk of death on recurrence. To date, TNBC is very …

Advanced cutaneous squamous cell carcinoma (cSCC) is treated with chemotherapy and/or
radiotherapy, but these typically fail to achieve satisfactory clinical outcomes. There have …

The transformation of a normal cell into a tumor cell is one of the initial steps in cell cycle
deregulation. The cell cycle is regulated by cyclin-dependent kinases (CDKs) that belong to …

Breast cancer is the most commonly diagnosed cancer in women and is one of the leading
causes of death from cancer in women worldwide. Despite the significant benefits of using …

Eribulin is a non-taxane synthetic analogue approved in many countries as third-line
treatment for the treatment of patients with metastatic breast cancer. In addition to its mitotic …

Adenoid cystic carcinoma (ACC) is a rare salivary glands tumor and often displays
aggressive behavior with frequent relapse and metastasis. The terminal ACC lacks standard …

The biology of breast cancer response to neoadjuvant therapy is underrepresented in the
literature and provides a window-of-opportunity to explore the genomic and …